Shenzhen - Delayed Quote CNY
Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ)
21.83
+0.62
+(2.92%)
At close: 3:04:19 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
380.87M
403.80M
422.17M
323.81M
461.21M
Cost of Revenue
122.31M
127.53M
145.45M
163.76M
166.33M
Gross Profit
258.56M
276.27M
276.72M
160.05M
294.88M
Operating Expense
251.02M
247.43M
252.31M
231.97M
235.50M
Operating Income
7.54M
28.84M
24.42M
-71.92M
59.38M
Net Non Operating Interest Income Expense
-1.26M
-1.14M
-825.48k
-452.06k
2.38M
Pretax Income
-1.49M
21.17M
13.81M
-90.71M
55.30M
Tax Provision
7.31M
10.27M
5.36M
-14.59M
1.98M
Net Income Common Stockholders
-8.21M
10.80M
8.28M
-75.98M
54.06M
Basic EPS
-0.07
0.09
0.07
-0.60
0.43
Diluted EPS
-0.07
0.09
0.07
-0.60
0.43
Basic Average Shares
126.13M
126.03M
125.99M
126.05M
126.05M
Diluted Average Shares
126.13M
126.03M
125.99M
126.05M
126.05M
Total Operating Income as Reported
-722.54k
23.49M
13.97M
-88.32M
55.79M
Rent Expense Supplemental
--
1.41M
1.86M
2.01M
1.86M
Total Expenses
373.33M
374.96M
397.75M
395.73M
401.83M
Net Income from Continuing & Discontinued Operation
-8.21M
10.80M
8.28M
-75.98M
54.06M
Normalized Income
-4.48M
12.92M
13.29M
-61.40M
60.65M
Interest Income
1.86M
1.98M
2.31M
2.08M
3.61M
Interest Expense
3.51M
3.07M
3.07M
2.47M
1.13M
Net Interest Income
-1.26M
-1.14M
-825.48k
-452.06k
2.38M
EBIT
2.02M
24.23M
16.88M
-88.24M
56.43M
EBITDA
2.02M
45.25M
35.31M
-68.65M
71.88M
Reconciled Cost of Revenue
122.31M
127.53M
145.45M
163.76M
166.33M
Reconciled Depreciation
--
21.02M
18.43M
19.59M
15.44M
Net Income from Continuing Operation Net Minority Interest
-8.21M
10.80M
8.28M
-75.98M
54.06M
Total Unusual Items Excluding Goodwill
-6.22M
-2.83M
-8.19M
-17.37M
-6.83M
Total Unusual Items
-6.22M
-2.83M
-8.19M
-17.37M
-6.83M
Normalized EBITDA
8.23M
48.08M
43.50M
-51.27M
78.71M
Tax Rate for Calcs
0.40
0.25
0.39
0.16
0.04
Tax Effect of Unusual Items
-2.49M
-706.54k
-3.18M
-2.79M
-244.88k
12/31/2021 - 12/13/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade